Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-09-08 Purchase | 2020-09-08 8:01 pm | VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer | 40,000 | $1.462 | $58,480 | 340,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-11-08 Disposition | 2023-11-13 2:40 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 114,140 | $0 | 0 (Direct) | View |
| 2023-11-08 Equity Swap | 2023-11-13 2:40 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 23,021 | $19 | 0 (Direct) | View |
| 2023-11-08 Disposition | 2023-11-13 2:40 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 45,244 | $19 | 0 (Direct) | View |
| 2023-09-21 Tax Withholding | 2023-09-25 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 908 | $10.8 | 68,265 (Direct) | View |
| 2023-06-21 Tax Withholding | 2023-06-23 4:04 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 908 | $11.74 | 69,173 (Direct) | View |
| 2023-03-21 Tax Withholding | 2023-03-23 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 909 | $14.19 | 70,081 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 4:05 pm | N/A 2033-01-27 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 38,700 | $0 | 94,990 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-03 4:04 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 718 | $12.37 | 56,290 (Direct) | View |
| 2022-12-21 Tax Withholding | 2022-12-23 4:03 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 908 | $13.43 | 57,008 (Direct) | View |
| 2022-09-21 Tax Withholding | 2022-09-23 4:02 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 908 | $14.85 | 57,916 (Direct) | View |
| 2022-06-21 Tax Withholding | 2022-06-23 4:01 pm | N/A N/A | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 3,632 | $12.48 | 58,824 (Direct) | View |
| 2022-01-27 Option Award | 2022-01-31 4:16 pm | N/A 2032-01-27 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 27,900 | $0 | 80,056 (Direct) | View |
| 2021-06-21 Option Award | 2021-06-22 7:01 pm | N/A 2031-06-21 | INTERCEPT PHARMACEUTICALS INC. | ICPT | Saik Andrew EVP & Chief Financial Officer | 124,696 | $0 | 124,696 (Direct) | View |
| 2021-05-28 Option Award | 2021-06-02 4:31 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer | 3,017 | $3.3575 | 116,468 (Direct) | View |
| 2021-03-31 Tax Withholding | 2021-04-02 12:14 pm | N/A N/A | VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer | 762 | $6.84 | 113,451 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-24 4:39 pm | N/A 2031-02-22 | VYNE Therapeutics Inc. | VYNE | Saik Andrew Chief Financial Officer | 97,375 | $0 | 182,375 (Direct) | View |
| 2020-05-06 Option Award | 2020-05-08 5:54 pm | N/A 2030-05-06 | Menlo Therapeutics Inc. | MNLO | Saik Andrew Chief Financial Officer | 250,000 | $0 | 550,000 (Direct) | View |
| 2020-03-23 Option Award | 2020-03-24 4:31 pm | N/A 2030-03-23 | Menlo Therapeutics Inc. | MNLO | Saik Andrew Chief Financial Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 4:30 pm | N/A N/A | PDS Biotechnology Corp | PDSB | Saik Andrew Chief Financial Officer | 38,400 | $1.3 | 42,549 (Direct) | View |
| 2019-06-06 Option Award | 2019-06-07 5:41 pm | N/A 2029-06-06 | PDS Biotechnology Corp | PDSB | Saik Andrew Chief Financial Officer | 62,715 | $0 | 62,715 (Direct) | View |